Back to Home
Novo Nordisk news
Novo Nordisk appears in 1 story we have published in October 2026, mostly in our Technology coverage. It is most often reported alongside Eli Lilly.
Latest development
Eli Lilly and Novo Nordisk report GLP-1 drugs may slow biological aging
Eli Lilly and Novo Nordisk have reported findings suggesting their blockbuster GLP-1 weight-loss drugs may slow biological aging by reducing molecular markers of age. The studies, presented at the Aging Research & Drug Discovery conference, used aging clocks to measure effects in overweight or diabetic patients. While the results are unverified, they could reshape the future of longevity therapeutics.
6 October 2026
